全文获取类型
收费全文 | 3729篇 |
免费 | 204篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 83篇 |
儿科学 | 100篇 |
妇产科学 | 104篇 |
基础医学 | 580篇 |
口腔科学 | 64篇 |
临床医学 | 314篇 |
内科学 | 788篇 |
皮肤病学 | 77篇 |
神经病学 | 378篇 |
特种医学 | 133篇 |
外科学 | 272篇 |
综合类 | 24篇 |
预防医学 | 280篇 |
眼科学 | 66篇 |
药学 | 436篇 |
中国医学 | 10篇 |
肿瘤学 | 247篇 |
出版年
2024年 | 4篇 |
2023年 | 48篇 |
2022年 | 188篇 |
2021年 | 275篇 |
2020年 | 94篇 |
2019年 | 145篇 |
2018年 | 160篇 |
2017年 | 116篇 |
2016年 | 140篇 |
2015年 | 129篇 |
2014年 | 177篇 |
2013年 | 235篇 |
2012年 | 314篇 |
2011年 | 295篇 |
2010年 | 163篇 |
2009年 | 138篇 |
2008年 | 182篇 |
2007年 | 237篇 |
2006年 | 227篇 |
2005年 | 193篇 |
2004年 | 155篇 |
2003年 | 115篇 |
2002年 | 104篇 |
2001年 | 17篇 |
2000年 | 14篇 |
1999年 | 10篇 |
1998年 | 8篇 |
1997年 | 9篇 |
1996年 | 5篇 |
1995年 | 6篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1984年 | 2篇 |
1980年 | 3篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1969年 | 3篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有3956条查询结果,搜索用时 15 毫秒
951.
Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease 总被引:3,自引:0,他引:3
Memon L Spasojević-Kalimanovska V Bogavac-Stanojević N Kalimanovska-Ostrić D Jelić-Ivanović Z Spasić S Topić A 《The Tohoku journal of experimental medicine》2006,209(3):197-206
Prospective studies have demonstrated that markers of inflammation, such as high-sensitivity C-reactive protein (hsCRP) and fibrinogen, predict future cardiovascular disease risk. However, the association between the hsCRP and fibrinogen levels and the extent of coronary stenosis in patients with coronary artery disease (CAD) remains controversial. The aim of our case-control study was to assess the association of inflammatory markers with the occurrence and extent of CAD. Serum hsCRP and plasma fibrinogen levels were measured in 138 patients with angiographically assessed CAD and in 183 healthy subjects matched according to age and gender. According to the number of significantly stenosed (>or= 50%) vessels, the patients were classified in four groups: those without stenosis (0-vessel disease) and those with 1, 2 or 3-vessel disease. The hsCRP and fibrinogen levels were significantly higher in patients than in controls (p < 0.001). Although the hsCRP and fibrinogen levels tended to increase with the number of stenotic vessels, the differences were only significant for hsCRP (p < 0.01). Regression analysis indicated hsCRP as an independent predictor for the presence (OR = 3.573, p < 0.05) and extent of CAD (beta = 1.095, p < 0.05). In conclusion, the present study is the first report concerning the frequency distribution of hsCRP in Serbian healthy subjects and CAD patients. We have shown that elevated levels of hsCRP are associated with the presence and extent of CAD. 相似文献
952.
Aleksandra Leligdowicz Clayton Onyango Louis‐Marie Yindom YanChun Peng Matthew Cotten Assan Jaye Andrew McMichael Hilton Whittle Sarah Rowland‐Jones 《European journal of immunology》2010,40(7):1963-1972
HIV‐1‐specific CD8+ T cells are present in most HIV‐1‐infected people and play an important role in controlling viral replication, but the characteristics of an effective HIV‐specific T‐cell response are largely unknown. The majority of HIV‐2‐infected people behave as long‐term non‐progressors while those who progress to AIDS do so in a manner indistinguishable from HIV‐1. A detailed study of HIV‐2 infection may identify protective immune responses. Robust gag p26‐specific T‐cell responses are elicited during HIV‐2 infection and correlate with control of viremia. In this study, we analyzed features of an HLA‐B*3501‐restricted T‐cell response to HIV‐2 p26 that may contribute to virus control. In contrast to HIV‐1, HIV‐2‐specific T cells are at an early stage of differentiation (CD27+CD28+), a finding that relates directly to CD4+ T‐cell levels and inversely to immune activation. The cells demonstrate IFN‐γ secretion, oligoclonal T‐cell receptor Vβ gene segment usage, exceptional avidity and secretion of pro‐inflammatory cytokines. Despite the potentially strong selection pressure imposed on the virus by these cells, there was no evidence of HIV‐2 sequence evolution. We propose that in chronic HIV‐2 infection, the maintenance of early‐differentiated, highly avid CD8+ T cells could account for the non‐progressive course of disease. Such responses may be desirable from an HIV vaccine. 相似文献
953.
Zaczek A Markiewicz A Supernat A Bednarz-Knoll N Brandt B Seroczyńska B Skokowski J Szade J Czapiewski P Biernat W Wełnicka-Jaśkiewicz M Jassem J 《Pathology oncology research : POR》2012,18(4):885-894
The aim of this study was to analyze the occurrence of TOP2A gene amplification and chromosome 17 polysomy in patients with early breast cancer and to correlate the status of these alterations with the prognostic significance expressed as patients' clinical features and survival. Such concurrent analyses of TOP2A gene status and chromosome 17 polysomy have not been performed before. Study group included 149 consecutive stage I-III patients administered standard multimodality treatment. TOP2A abnormalities were examined by standard fluorescence in situ hybridization (FISH) and developed by our group quantitative real-time PCR (qPCR). TOP2A amplification and deletion assessed by FISH were found in 23% and 7% of the tumours, respectively, and by qPCR in 31% and 11% of the tumours, respectively. Chromosome 17 polysomy was detected in 40% of the cases. TOP2A amplification (by qPCR) correlated with shorter disease-free survival (p?=?0.03) and overall survival (p?=?0.047), and the prognostic value of TOP2A was confirmed in the multivariate analysis (HR?=?3.22, 95% CI 1.09-9.56, p?=?0.03). TOP2A gene amplification, but not chromosome 17 polysomy, carries negative prognostic information in early breast cancer. Given the aforementioned results, qPCR might serve as a prognostic tool in determining the patient's prognosis. 相似文献
954.
Djunic I Virijevic M Djurasinovic V Novkovic A Colovic N Kraguljac-Kurtovic N Vidovic A Suvajdzic-Vukovic N Tomin D 《Medical oncology (Northwood, London, England)》2012,29(3):2077-2082
The aims of this study were to investigate the frequency and prognostic relevance of CD56 expression in patients with acute myeloid leukemia (AML) and to compare the importance of CD56 expression with standard prognostic factors, such as age, leukocytosis, cytogenetic abnormalities and performance status. We analyzed the data of 184 newly diagnosed patients with non-promyelocytic AML and a follow-up of 36 months. The median patient age was 58 years, with a range of 18-79. CD56+ antigen was recorded in 40 patients (21.7%). CD56 + was the most significant risk factor for OS: P = 0.05. The most significant factor for a poor rate of CR was age ≥ 55 years (P = 0.001). CD56 positivity had no significant influence on CR rate, but it was the most significant risk factor for disease-free survival (P = 0.005). The CD56 antigen is an independent prognostic risk factor, and its presence should be measured regularly for a better prognostic assessment of patients with AML. 相似文献
955.
Djunic I Virijevic M Novkovic A Djurasinovic V Colovic N Vidovic A Suvajdzic-Vukovic N Tomin D 《Medical oncology (Northwood, London, England)》2012,29(2):1077-1081
This single-center study estimated the significance of pretreatment factors, including comorbidities, which may predict outcome
in elderly patients with acute myeloid leukemia and determined how poor risk factors may be used as decision criteria for
intensity of chemotherapy in this group of patients. Seventy-seven patients aged ≥ 55 years treated under four different regimens
were followed up 36 month. Our results suggest that the most significant predictor for poor overall survival is comorbidity,
as scored by the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), P = 0.008. The most significant predictor for rate of complete remission is serum lactate dehydrogenase (LDH) level, P = 0.049, and the most significant predictor of early death is leucocytosis, P = 0.007. HCT-CI ≥ 3 was the most significant factor for treatment decision making regarding intensity of chemotherapy. The
use of standardized comorbidity assessment tools, such as HCT-CI, for elderly patients with AML is practical and can help
to improve treatment decision regarding the intensity of chemotherapy. 相似文献
956.
Munding JB Adai AT Maghnouj A Urbanik A Zöllner H Liffers ST Chromik AM Uhl W Szafranska-Schwarzbach AE Tannapfel A Hahn SA 《International journal of cancer. Journal international du cancer》2012,131(2):E86-E95
Pancreatic ductal adenocarcinoma (PDAC) is known for its poor prognosis resulting from being diagnosed at an advanced stage. Accurate early diagnosis and new therapeutic modalities are therefore urgently needed. MicroRNAs (miRNAs), considered a new class of biomarkers and therapeutic targets, may be able to fulfill those needs. Combining tissue microdissection with global miRNA array analyses, cell type-specific miRNA expression profiles were generated for normal pancreatic ductal cells, acinar cells, PDAC cells derived from xenografts and also from macrodissected chronic pancreatitis (CP) tissues. We identified 78 miRNAs differentially expressed between ND and PDAC cells providing new insights into the miRNA-driven pathophysiological mechanisms involved in PDAC development. Having filtered miRNAs which are upregulated in the three pairwise comparisons of PDAC vs. ND, PDAC vs. AZ and PDAC vs. CP, we identified 15 miRNA biomarker candidates including miR-135b. Using relative qRT-PCR to measure miR-135b normalized to miR-24 in 75 FFPE specimens (42 PDAC and 33 CP) covering a broad range of tumor content, we discriminated CP from PDAC with a sensitivity and specificity of 92.9% [95% CI=(80.5, 98.5)] and 93.4% [95% CI=(79.8, 99.3)], respectively. Furthermore, the area under the curve (AUC) value reached of 0.97 was accompanied by positive and negative predictive values of 95% and 91%, respectively. In conclusion, we report pancreatic cell-specific global miRNA profiles, which offer new candidate miRNAs to be exploited for functional studies in PDAC. Furthermore, we provide evidence that miRNAs are well-suited analytes for development of sensitive and specific aid-in-diagnosis tests for PDAC. 相似文献
957.
958.
Beatrice Paradiso Peggy Marconi Silvia Zucchini Elena Berto Anna Binaschi Aleksandra Bozac Andrea Buzzi Manuela Mazzuferi Eros Magri Graciela Navarro Mora Donata Rodi Tao Su Ilaria Volpi Lara Zanetti Andrea Marzola Roberto Manservigi Paolo F. Fabene Michele Simonato 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(17):7191-7196
A loss of neurons is observed in the hippocampus of many patients with epilepsies of temporal lobe origin. It has been hypothesized that damage limitation or repair, for example using neurotrophic factors (NTFs), may prevent the transformation of a normal tissue into epileptic (epileptogenesis). Here, we used viral vectors to locally supplement two NTFs, fibroblast growth factor–2 (FGF-2) and brain-derived neurotrophic factor (BDNF), when epileptogenic damage was already in place. These vectors were first characterized in vitro, where they increased proliferation of neural progenitors and favored their differentiation into neurons, and they were then tested in a model of status epilepticus-induced neurodegeneration and epileptogenesis. When injected in a lesioned hippocampus, FGF-2/BDNF expressing vectors increased neuronogenesis, embanked neuronal damage, and reduced epileptogenesis. It is concluded that reduction of damage reduces epileptogenesis and that supplementing specific NTFs in lesion areas represents a new approach to the therapy of neuronal damage and of its consequences. 相似文献
959.
Muscle biopsy is required to provide a definitive diagnosis in many neuromuscular disorders. Biopsy findings may indicate whether the pathological process is of neurogenic or myopathic origin. The muscle biopsy may give important information on the course of the disease (acute or chronic) and on the disease stage and progression. The interpretation of muscle biopsy, including histochemical and ultrastructural analysis, is a key factor in the diagnosis of muscular dystrophies, glycogenoses, inflammatory myopathies and congenital myopathies. An assessment of muscle biopsy on electron microscopy enables a definite diagnosis of oculopharyngeal muscular dystrophy, mitochondrial myopathy or inclusion body myositis. This paper presents an overview of general indications for muscle biopsy, biopsy procedures, as well as transportation and preparation of muscle tissue for final microscopic analysis. The interpretation of specific microscopic findings and a brief discussion on the clinical usefulness of muscle biopsy in the era of molecular diagnosis are also presented. 相似文献
960.
Klimkowicz-Mrowiec A Wołkow P Spisak K Maruszak A Styczyńska M Barcikowska M Szczudlik A Słowik A 《Neurologia i neurochirurgia polska》2010,44(6):537-541
Background and purposeInflammation plays a prominent role in Alzheimer disease (AD) pathogenesis. Interleukin-6 (IL-6), a pro-inflammatory cytokine, and some genetic variations in the IL-6 gene have been reported to be associated with a risk of AD. However, the results of the conducted studies are equivocal.Material and methodsWe genotyped IL-6 (–174 C/G) and apolipoprotein E gene (APOE) common polymorphisms in a large case-controlled study in a Polish population. We included 361 patients aged ≥ 65 years with AD (mean age 75.8 ± 5.3 years, 232 females [64.3%]) and 200 controls (75.3 ± 7.4 years; 119 females [59.5%]), without any neurological deficit, cognitive complaints or history of neurological diseases. The IL-6 polymorphism was genotyped using TaqMan SNP allelic discrimination by means of an ABI 7900HT (Applied Biosystems, Foster City, CA).ResultsThe distribution of the IL-6 (–174 C/G) genotypes was similar to that in the controls (AD: C/C = 15.79%, C/G = 51.25%, G/G = 32.96% vs. controls: C/C = 21.50%, C/G = 45.50%, G/G = 33.0%, p > 0.05). Our study confirms previous reports that APOE 4 is strongly related to the risk of AD (OR = 6.17; 95% CI: 4.01–9.49). APOE status did not affect the distribution of the studied IL-6 polymorphism.ConclusionIL-6 (–174 C/G) polymorphism is not a risk factor for late onset AD in a Polish population. 相似文献